Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes

Patients with type 2 diabetes (T2D) are characterized by blunted immune responses, which are affected by glycaemic control. Whether glycaemic control influences the response to COVID-19 vaccines and the incidence of SARS-CoV-2 breakthrough infections is unknown. Here we show that poor glycaemic cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Marfella, Raffaele, Sardu, Celestino, D’Onofrio, Nunzia, Prattichizzo, Francesco, Scisciola, Lucia, Messina, Vincenzo, La Grotta, Rosalba, Balestrieri, Maria Luisa, Maggi, Paolo, Napoli, Claudio, Ceriello, Antonio, Paolisso, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051134/
https://www.ncbi.nlm.nih.gov/pubmed/35484164
http://dx.doi.org/10.1038/s41467-022-30068-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051134/
https://www.ncbi.nlm.nih.gov/pubmed/35484164
http://dx.doi.org/10.1038/s41467-022-30068-2

Ejemplares similares